The website for the Macauley Lab has gone live today. Click here to visit for information on current research, publications, as well as collaboration and employment opportunities.
“A University of Alberta biotechnology spinoff wants to put Edmonton at the epicentre of molecular discoveries by creating an immense searchable database that could speed up and drive down the cost of research and development.” Click here for the full article in the Edmonton Journal.
The Alberta Glycomics Centre is proud to support the launch of biotech spin-off company 48Hour Discovery Inc., an Alberta-based company providing services in ligand discovery in unprecedented turnaround time and within a fully manageable costing model. Founded in February 2017, 48HD’s core business is rooted in a proprietary molecular discovery platform emanating from the expertise and intellectual property generated from the Derda Research Group under the AGC research and commercialization umbrella. The company provides rapid ligand discovery services for any target using its expansive portfolio of genetically-encoded molecules, mining technology, and a standardized discovery protocol. More to follow on this…
AGC Director Dr. John Klassen’s co-authored article “Investigating the Influence of Membrane Composition on Protein-Glycolipid Binding Using Nanodiscs and Proxy Ligand ESI-MS” has been accepted for publication in Analytical Chemistry. Watch this site for updates and links.
AGC Director Dr. John Klassen’s co-authored article “High Throughput, Label- and Immobilization-Free Screening of Human Milk Oligosaccharides Against Lectins” has been accepted for publication in Analytical Chemistry. Watch this site for updates and links.